Published in Neuropsychiatr Dis Treat on March 07, 2017
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry (1992) 33.67
Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA (2009) 8.40
A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med (2006) 8.12
Aromatic amino acids and modification of parkinsonism. N Engl J Med (1967) 5.46
Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med (2010) 5.27
Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med (2004) 4.56
Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain (2007) 4.13
Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Lancet Neurol (2012) 3.98
Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol (2005) 3.78
Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol (2010) 3.56
Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology (2012) 3.46
Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol (1987) 3.14
Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg (1992) 3.01
STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology (2008) 2.93
Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology (2006) 2.90
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet (2013) 2.71
Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol (2010) 2.64
Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord (2006) 2.53
Directional deep brain stimulation: an intraoperative double-blind pilot study. Brain (2014) 2.31
Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol (2009) 2.29
Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain (2000) 2.25
Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord (2010) 2.20
Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease. Mov Disord (2011) 2.12
An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci (2002) 2.08
Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology (2002) 1.96
Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain (2009) 1.91
Ligation of the anterior choroidal artery for involuntary movements; parkinsonism. Psychiatr Q (1953) 1.90
Basic algorithms for the programming of deep brain stimulation in Parkinson's disease. Mov Disord (2006) 1.89
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease. Mov Disord (2011) 1.70
Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch Neurol (2011) 1.65
Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study. Lancet Neurol (2015) 1.58
Deep brain stimulation: postoperative issues. Mov Disord (2006) 1.57
The pressor response to water drinking in humans : a sympathetic reflex? Circulation (2000) 1.52
Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2010) 1.50
Motor complications in an incident Parkinson's disease cohort. Eur J Neurol (2015) 1.44
Ten-Hertz stimulation of subthalamic nucleus deteriorates motor symptoms in Parkinson's disease. Mov Disord (2004) 1.40
Latest view on the mechanism of action of deep brain stimulation. Mov Disord (2008) 1.39
Adaptive deep brain stimulation (aDBS) controlled by local field potential oscillations. Exp Neurol (2012) 1.35
Mechanism of action of deep brain stimulation. Neurology (2000) 1.33
Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease. N Engl J Med (2000) 1.32
What brain signals are suitable for feedback control of deep brain stimulation in Parkinson's disease? Ann N Y Acad Sci (2012) 1.31
Postoperative management of subthalamic nucleus stimulation for Parkinson's disease. Mov Disord (2002) 1.29
Water drinking acutely improves orthostatic tolerance in healthy subjects. Circulation (2002) 1.25
Long-term results of bilateral pallidal stimulation in Parkinson's disease. Ann Neurol (2004) 1.17
Bilateral subthalamotomy in Parkinson's disease: initial and long-term response. Brain (2005) 1.16
Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology (2014) 1.15
Multicentre European study of thalamic stimulation for parkinsonian tremor: a 6 year follow-up. J Neurol Neurosurg Psychiatry (2007) 1.11
Oscillatory local field potentials recorded from the subthalamic nucleus of the alert rat. Exp Neurol (2002) 1.07
Hardware-related complications of deep brain stimulation: a review of the published literature. Stereotact Funct Neurosurg (2006) 1.07
Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease. J Neurosurg (2014) 1.05
Closed-loop neurostimulation: the clinical experience. Neurotherapeutics (2014) 1.05
Deep brain stimulation does not silence neurons in subthalamic nucleus in Parkinson's patients. J Neurophysiol (2009) 1.05
Thirty days complication rate following surgery performed for deep-brain-stimulation. Mov Disord (2007) 1.03
Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B). Mov Disord (2014) 1.02
Impulse control disorders in Parkinson's disease: prevalence and possible risk factors. Parkinsonism Relat Disord (2009) 0.99
Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management. Parkinsonism Relat Disord (2009) 0.94
Lesion therapy for Parkinson's disease and other movement disorders: update and controversies. Mov Disord (2004) 0.94
Deep brain stimulation: new techniques. Parkinsonism Relat Disord (2014) 0.93
Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study. Mov Disord (2008) 0.92
Surgical alleviation of Parkinsonism; effects of occlusion of the anterior choroidal artery. J Am Geriatr Soc (1954) 0.91
Deep brain stimulation entrains local neuronal firing in human globus pallidus internus. J Neurophysiol (2012) 0.91
STN vs. GPi Deep Brain Stimulation: Translating the Rematch into Clinical Practice. Mov Disord Clin Pract (2014) 0.90
Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience. Eur J Neurol (2013) 0.90
Long-term surgical and hardware-related complications of deep brain stimulation. Stereotact Funct Neurosurg (2011) 0.89
Tremor Reduction by Deep Brain Stimulation Is Associated With Gamma Power Suppression in Parkinson's Disease. Neuromodulation (2015) 0.88
Cognitive impairment and dementia in Parkinson's disease: practical issues and management. Mov Disord (2014) 0.88
Neuroleptic malignant syndrome or parkinsonism hyperpyrexia syndrome. Semin Neurol (1991) 0.87
Hallucinations and psychosis in Parkinson's disease. Parkinsonism Relat Disord (2009) 0.85
Confined stimulation using dual thalamic deep brain stimulation leads rescues refractory essential tremor: report of three cases. Stereotact Funct Neurosurg (2009) 0.84
Commentary: the pedunculopontine nucleus: clinical experience, basic questions and future directions. J Neural Transm (Vienna) (2010) 0.84
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? Parkinsonism Relat Disord (2014) 0.84
Risk and course of motor complications in a population-based incident Parkinson's disease cohort. Parkinsonism Relat Disord (2015) 0.83
Advanced therapies in Parkinson's disease: Long-term retrospective study. Parkinsonism Relat Disord (2016) 0.82
Efficacy and safety of deep brain stimulation as an adjunct to pharmacotherapy for the treatment of Parkinson disease. Ann Pharmacother (2012) 0.82
The factors involved in deep brain stimulation infection: a large case series. Stereotact Funct Neurosurg (2014) 0.81
Physiology of freezing of gait. Ann Neurol (2016) 0.81
Subthalamic stimulation may inhibit the beneficial effects of levodopa on akinesia and gait. Mov Disord (2016) 0.80
Efficacy and Safety of Pedunculopontine Nuclei (PPN) Deep Brain Stimulation in the Treatment of Gait Disorders: A Meta-Analysis of Clinical Studies. Can J Neurol Sci (2016) 0.79
Rescue leads: a salvage technique for selected patients with a suboptimal response to standard DBS therapy. Parkinsonism Relat Disord (2011) 0.79
Proceedings of the Fourth Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies. Front Integr Neurosci (2016) 0.78
Low-frequency deep brain stimulation for Parkinson's disease: Great expectation or false hope? Mov Disord (2016) 0.78
60-Hz frequency effect on gait in Parkinson's disease with subthalamic nucleus deep brain stimulation. Neuromodulation (2013) 0.78
Directional deep brain stimulation of the subthalamic nucleus: A pilot study using a novel neurostimulation device. Mov Disord (2016) 0.77
Cost of deep brain stimulation for the treatment of Parkinson's disease by surgical stimulation sites. Mov Disord (2014) 0.77
Pedunculopontine Nucleus Region Deep Brain Stimulation in Parkinson Disease: Surgical Techniques, Side Effects, and Postoperative Imaging. Stereotact Funct Neurosurg (2016) 0.77
A meta-analysis of the pedunculopontine nucleus deep-brain stimulation effects on Parkinson's disease. Neuroreport (2016) 0.76
Surgical Treatment of Parkinson's Disease. Curr Treat Options Neurol (2016) 0.76
Complication rates, lengths of stay, and readmission rates in "awake" and "asleep" deep brain simulation. J Neurosurg (2016) 0.76
Electromagnetic environmental influences on implanted deep brain stimulators. Neuromodulation (2006) 0.76
The new definition and diagnostic criteria of Parkinson's disease. Lancet Neurol (2016) 0.76
Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs. Parkinsonism Relat Disord (2016) 0.76
The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations. Mov Disord (2016) 0.76
Low-frequency Subthalamic Stimulation in Parkinson's Disease: Long-term Outcome and Predictors. Brain Stimul (2016) 0.76
Bowstringing as a complication of deep brain stimulation: case report. Neurosurgery (2010) 0.76
Wire tethering or 'bowstringing' as a long-term hardware-related complication of deep brain stimulation. Stereotact Funct Neurosurg (2009) 0.76
Mechanism of action for deep brain stimulation and electrical neuro-network modulation (ENM). Rinsho Shinkeigaku (2013) 0.76
Rescue Procedures after Suboptimal Deep Brain Stimulation Outcomes in Common Movement Disorders. Brain Sci (2016) 0.75